Source:http://linkedlifedata.com/resource/pubmed/id/21561155
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
2011-7-7
|
pubmed:databankReference | |
pubmed:abstractText |
1-Deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) is a novel target for developing new antibacterial (including antituberculosis) and antimalaria drugs. Forty-one lipophilic phosphonates, representing a new class of DXR inhibitors, were synthesized, among which 5-phenylpyridin-2-ylmethylphosphonic acid possesses the most activity against E. coli DXR (EcDXR) with a K(i) of 420 nM. Structure-activity relationships (SAR) are discussed, which can be rationalized using our EcDXR:inhibitor structures, and a predictive quantitative SAR (QSAR) model is also developed. Since inhibition studies of DXR from Mycobacterium tuberculosis (MtDXR) have not been performed well, 48 EcDXR inhibitors with a broad chemical diversity were found, however, to generally exhibit considerably reduced activity against MtDXR. The crystal structure of a MtDXR:inhibitor complex reveals the flexible loop containing the residues 198-208 has no strong interactions with the 3,4-dichlorophenyl group of the inhibitor, representing a structural basis for the reduced activity. Overall, these results provide implications in the future design and development of potent DXR inhibitors.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-deoxy-D-xylulose 5-phosphate...,
http://linkedlifedata.com/resource/pubmed/chemical/Aldose-Ketose Isomerases,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antitubercular Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Multienzyme Complexes,
http://linkedlifedata.com/resource/pubmed/chemical/Oxidoreductases,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphonic Acids
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1520-4804
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
14
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4721-34
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:21561155-Aldose-Ketose Isomerases,
pubmed-meshheading:21561155-Anti-Bacterial Agents,
pubmed-meshheading:21561155-Antitubercular Agents,
pubmed-meshheading:21561155-Crystallography, X-Ray,
pubmed-meshheading:21561155-Escherichia coli,
pubmed-meshheading:21561155-Models, Molecular,
pubmed-meshheading:21561155-Multienzyme Complexes,
pubmed-meshheading:21561155-Mycobacterium tuberculosis,
pubmed-meshheading:21561155-Oxidoreductases,
pubmed-meshheading:21561155-Phosphonic Acids,
pubmed-meshheading:21561155-Protein Binding,
pubmed-meshheading:21561155-Protein Conformation,
pubmed-meshheading:21561155-Quantitative Structure-Activity Relationship,
pubmed-meshheading:21561155-Structure-Activity Relationship
|
pubmed:year |
2011
|
pubmed:articleTitle |
Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase by lipophilic phosphonates: SAR, QSAR, and crystallographic studies.
|
pubmed:affiliation |
Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77030, United States.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|